[{"uuid": "1abab087-f243-38ca-9e31-ec065deac03d", "title": "Nuvve Selects Tellus as a Key Hardware Supplier for its Charging Solutions", "publisher": "Business Wire", "link": "https://finance.yahoo.com/news/nuvve-selects-tellus-key-hardware-133000149.html", "providerPublishTime": 1738243800, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/JLZGwa3r2oH5kAmFIcNuCA--~B/aD00ODA7dz0zNzY7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/2f28eae65323af854d7a5f2411e85b01", "width": 376, "height": 480, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/7hHIm5kkKWNaJyjjngTdvg--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/2f28eae65323af854d7a5f2411e85b01", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["NVVE", "NVVEW"]}, {"uuid": "9561837a-4b1c-3008-bd74-56fe42bef71b", "title": "Apellis Pharmaceuticals' Geographic Atrophy Treatment Gets Approval From Australian Therapeutic Goods Administration", "publisher": "MT Newswires", "link": "https://finance.yahoo.com/news/apellis-pharmaceuticals-apos-geographic-atrophy-224428922.html", "providerPublishTime": 1738017868, "type": "STORY", "relatedTickers": ["APLS"]}, {"uuid": "7b2eadf9-3748-31f8-88ce-37bb77f1f55e", "title": "Sector Update: Health Care Stocks Edge Higher Pre-Bell Tuesday", "publisher": "MT Newswires", "link": "https://finance.yahoo.com/news/sector-health-care-stocks-edge-141652187.html", "providerPublishTime": 1738073812, "type": "STORY", "relatedTickers": ["APLS"]}, {"uuid": "f5a69c8b-7149-321f-bef7-860eca7e6b65", "title": "Sector Update: Health Care", "publisher": "MT Newswires", "link": "https://finance.yahoo.com/news/sector-health-care-135639079.html", "providerPublishTime": 1738072599, "type": "STORY", "relatedTickers": ["APLS"]}, {"uuid": "d94cec60-8591-3b81-a163-432afb96cf9e", "title": "Apellis Receives Approval of SYFOVRE\u00ae (pegcetacoplan) in Australia for Geographic Atrophy (GA)", "publisher": "GlobeNewswire", "link": "https://finance.yahoo.com/news/apellis-receives-approval-syfovre-pegcetacoplan-210000820.html", "providerPublishTime": 1738011600, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/Z51c.MMIjja0fQp_Bb90cw--~B/aD01NDt3PTE2ODthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/globenewswire.com/ee6969fd8bbd71bc3d94e172ead4fbb7", "width": 168, "height": 54, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/AaYw7dKLB_NyZthqheilBg--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/ee6969fd8bbd71bc3d94e172ead4fbb7", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["APLS"]}, {"uuid": "8b0b8368-dc97-3a13-bcea-ce470f9d3697", "title": "Pfizer\u2019s BRAFTOVI\u00ae Combination Regimen Demonstrates Improved Response in Patients with BRAF V600E-Mutant Metastatic Colorectal Cancer", "publisher": "Business Wire", "link": "https://finance.yahoo.com/news/pfizer-braftovi-combination-regimen-demonstrates-200000443.html", "providerPublishTime": 1737835200, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/bGYrNOSZcAfTiqDOXW296A--~B/aD0yMTI7dz00ODA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/7360f288c60691165e7366698cbfdb65", "width": 480, "height": 212, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/sOqhtrSUd_MvnahxXL5zNw--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/7360f288c60691165e7366698cbfdb65", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["PFE"]}, {"uuid": "7a7fa7cd-4c26-3886-9af2-eeaaccad30de", "title": "Wedbush Raises Price Target on Apellis Pharmaceuticals to $30 From $25, Keeps Neutral Rating", "publisher": "MT Newswires", "link": "https://finance.yahoo.com/news/wedbush-raises-price-target-apellis-123840579.html", "providerPublishTime": 1737635920, "type": "STORY", "relatedTickers": ["APLS"]}, {"uuid": "5e57036d-48ba-3e10-adcf-6b4b0ca9f886", "title": "Apellis Pharmaceuticals Insider Sold Shares Worth $412,296, According to a Recent SEC Filing", "publisher": "MT Newswires", "link": "https://finance.yahoo.com/news/apellis-pharmaceuticals-insider-sold-shares-203214696.html", "providerPublishTime": 1737664334, "type": "STORY", "relatedTickers": ["APLS"]}, {"uuid": "8d246d32-847a-35ed-87d2-51ea93108cea", "title": "Apellis Shares Rise After Reporting Preliminary Q4, Full-Year Product Sales Results", "publisher": "MT Newswires", "link": "https://finance.yahoo.com/news/apellis-shares-rise-reporting-preliminary-192346012.html", "providerPublishTime": 1736796226, "type": "STORY", "relatedTickers": ["APLS"]}, {"uuid": "47774cae-87f5-3b63-b794-91960cbfa7ba", "title": "Apellis Highlights Commercial Growth and Strategic Priorities at 43rd Annual J.P. Morgan Healthcare Conference", "publisher": "GlobeNewswire", "link": "https://finance.yahoo.com/news/apellis-highlights-commercial-growth-strategic-140000263.html", "providerPublishTime": 1736776800, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/Z51c.MMIjja0fQp_Bb90cw--~B/aD01NDt3PTE2ODthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/globenewswire.com/ee6969fd8bbd71bc3d94e172ead4fbb7", "width": 168, "height": 54, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/AaYw7dKLB_NyZthqheilBg--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/ee6969fd8bbd71bc3d94e172ead4fbb7", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["APLS"]}, {"uuid": "c51b9f36-a538-3e92-9965-aef4c7fd0c73", "title": "Sector Update: Health Care Stocks Rise Late Afternoon", "publisher": "MT Newswires", "link": "https://finance.yahoo.com/news/sector-health-care-stocks-rise-210828254.html", "providerPublishTime": 1736802508, "type": "STORY", "relatedTickers": ["SLRX", "JNJ"]}, {"uuid": "95156186-a267-344b-8f6d-51a732c4ad27", "title": "Apellis Announces Keli Walbert to Join the Board of Directors", "publisher": "GlobeNewswire", "link": "https://finance.yahoo.com/news/apellis-announces-keli-walbert-join-120000212.html", "providerPublishTime": 1736510400, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/Z51c.MMIjja0fQp_Bb90cw--~B/aD01NDt3PTE2ODthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/globenewswire.com/ee6969fd8bbd71bc3d94e172ead4fbb7", "width": 168, "height": 54, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/AaYw7dKLB_NyZthqheilBg--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/ee6969fd8bbd71bc3d94e172ead4fbb7", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["APLS"]}]